Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
about
Enhancing oral vaccine potency by targeting intestinal M cellsPlant Viruses as Nanoparticle-Based Vaccines and AdjuvantsChemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs)Is there a role for plant-made vaccines in the prevention of HIV/AIDS?Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches.Transgenic plants as factories for biopharmaceuticals.Use of viral vectors for vaccine production in plants.Activation of B cells by a dendritic cell-targeted oral vaccine.A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.Advantageous features of plant-based systems for the development of HIV vaccines.Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Intranasal delivery of vaccines against HIV.Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case studyPlant-made immunogens and effective delivery strategies.Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).The therapeutic potential of plant-derived vaccines and antibodies.Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis.High-yield expression of a viral peptide vaccine in transgenic plants.Immune response induced in mice oral immunization with cowpea severe mosaic virus.Use of Plant Viruses for Production of Plant-Derived Vaccines
P2860
Q21089613-47345A69-DF8F-49E6-B9A1-EC7A866C8898Q26782569-CF150A1C-BC8D-42D4-A206-EB95A72B8214Q28473681-BA050974-EE6A-453F-92F6-C3876D17FF55Q30350670-EA5322B4-A291-4C0D-882A-DC39D63D5C41Q30392083-73A7DD1A-162A-4D41-8412-D55E1846D74FQ34076132-99AEFBB3-D413-4A3A-AA7F-7E1F05CA474CQ34416460-3763F82B-FC90-4B8B-A507-ED0B747FC8C0Q34979404-E9D3467D-CE01-4963-ACA8-19BAC221832DQ35048518-34339BBF-1FA6-4794-A694-D760D5B04C4FQ35809251-695810F5-6649-4A04-A39C-878D41D9FBF9Q35960908-2B60FBAC-3B0F-4FEC-939E-5067B95C942AQ36409054-9E041DA1-9EB6-491A-9588-C9A3E5D21EB1Q37377681-640F7A89-D46F-4404-9B8E-37612C68AB71Q37776713-2930A67D-F201-4174-B206-6B1AC54B12A8Q37967232-210EE430-39EC-40A2-AF3C-E475791D7F8FQ40408971-0F67D2AE-B2C6-42C7-9661-0161EFDB6331Q42126332-36CBE823-7F57-464F-ACCF-A84D5FCC9B6BQ44911177-5B385E6B-7241-4A4C-A26B-579EEFEE28BCQ45731670-32F4AEC9-536A-45A0-A697-49C94496904EQ57261183-C6639715-68F8-44E0-9406-89BA202B4BD3
P2860
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intranasal immunization with a ...... nd IgG than oral immunization.
@ast
Intranasal immunization with a ...... nd IgG than oral immunization.
@en
type
label
Intranasal immunization with a ...... nd IgG than oral immunization.
@ast
Intranasal immunization with a ...... nd IgG than oral immunization.
@en
prefLabel
Intranasal immunization with a ...... nd IgG than oral immunization.
@ast
Intranasal immunization with a ...... nd IgG than oral immunization.
@en
P2093
P1476
Intranasal immunization with a ...... nd IgG than oral immunization.
@en
P2093
Brennan FR
Dimmock NJ
McInerney TL
P304
P356
10.1016/S0022-1759(98)00145-8
P577
1998-11-01T00:00:00Z